AVAH
Aveanna Healthcare Holdings Inc. Common Stock
SERVICES-HOME HEALTH CARE SERVICES
Aveanna Healthcare (AVAH) Stock: Buy, Sell, or Hold?
$11.50
-0.74 (-6.05%)
▼
5d:
-13.21%
30d:
-9.02%
90d:
-9.38%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
0d
Protect AVAH Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
41/100
Position
OVERSOLD
30-Day Fair Range
$12.24 – $13.37
Position: OVERSOLD
Forward P/E & Valuation
12.7x
FAIR
vs 12.5x historical avg
Wall Street Target
$15.10
+31.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$11.31 / $14.55
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: AVAH is down 13.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 12, 2026 at $12.34 · last confirmed Nov 13, 2026
Strength: 7.9/10
Get Alerted When AVAH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$14.68
Based on 5.4% avg growth
INTRINSIC VALUE TODAY
$9.11
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AVAH is currently trading at $11.50, which is considered oversold relative to its 30-day fair value range of $12.24 to $13.37. The stock's valuation (Forward PE: 12.7) is in line with its historical norms (12.5). At these levels, the market is pricing in 0.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AVAH is in a strong uptrend. The price is currently testing key support at $11.31. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: AVAH scores 19/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $15.10 (+31.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AVAH is in a strong uptrend. The price is currently testing key support at $11.31. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: AVAH scores 19/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $15.10 (+31.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$12.24 -
$13.37
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
53.3%
Trading Range & Key Levels
30-Day Trading Range
$12.24 -
$13.37
Current vs Trading Range
OVERSOLD
Support Level
$11.31
Resistance Level
$14.55
Current Trend
Strong Uptrend
Technical data as of
Nov 13, 2026
Protect Your Profits
Holding AVAH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (19/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.0%)
- BULLISH: Trading 31.3% below Wall St target ($15.10)
- NEUTRAL: Market pricing in 0.6% annual earnings growth - fairly valued
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
12.71
Wall Street Target
$15.10
(+31.3%)
Revenue Growth (YoY)
11.8%
Earnings Growth (YoY)
233.3%
Profit Margin
11.4%
Valuation Premium vs History
+0.6% premium
PE vs Historical
12.7 vs 12.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.6%
(market-implied from PE analysis)
1-Year Target
$11.57
(+1%)
2-Year Target
$11.64
(+1%)
3-Year Target
$11.71
(+2%)
3-Yr Target (if PE normalizes)
(PE: 13→13)
PE COMPRESSION
$11.52
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 6.7%)
$21.85
(+90%)
Base:
(SPY PE: 12.7, Growth: 6.7%)
$13.98
(+22%)
Bear:
(PE: 10.8, Growth: 6.7%)
$11.88
(+3%)
📈
Valuation based on Current Earnings
Trailing PE: 9.71 | Current EPS (TTM): $1.26
Bull Case
$9.67
(-16%)
Analyst growth -28.2%, PE expands to 10.7
Base Case
$8.79
(-24%)
Market implied -28.2%, PE stable at 9.7
Bear Case
$8.32
(-28%)
Severe decline -20.0%, PE contracts to 8.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share AVAH Analysis
Share this live AVAH analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (AVAH)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jun 3, 2026
Daily AI digest
AI Retail Discussion Summary:
Aveanna Healthcare (AVAH) raised its 2026 guidance following the closure of its acquisition of Family First Homecare, which strengthens the company's Private Duty Nursing presence in key markets.
Key Retail Themes:
growth strategy
acquisition
market expansion
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 15, 2026 12:20 AM ET
Data refreshes hourly during market hours. Next update: 1:20 AM
Data refreshes hourly during market hours. Next update: 1:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVAH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$306 | 45 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$477 | 37 SELL |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$156 | 42 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
11 analysts |
$44 | 49 HOLD |
Advanced AVAH Option Strategies
Professional options setups generated by AI based on today's AVAH price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive AVAH Research Pages
